A method was developed for the well-defined coupling of phosphoethanolamine group (PEA)-and carboxylic acid group-containing polysaccharides and oligosaccharides to proteins without the need for extensive modification of the carbohydrate antigens. The carboxylic acid group of the terminal 2-keto-3-deoxyoctulosonic acid moiety was utilized to introduce a thiol function in meningococcal immunotype L2 and L3,7,9 lipopolysaccharide-derived oligosaccharides. The thiol group-containing oligosaccharides were subsequently coupled to bromoacetylated proteins. Immunotype L2 and L3,7,9 PEA group-containing oligosaccharidetetanus toxoid conjugates were prepared, and their immunogenicities were studied in rabbits. Both the immunotype L2 and immunotype L3,7,9 conjugates evoked high immunoglobulin G (IgG) antibody titers after the first booster injection. These conjugates also displayed an ability to induce long-lasting IgG antibody levels which could be detected until 9 months after one booster injection at week 3. The adjuvant Quil A enhanced the immune response to all the conjugates to a minor extent, which is in contrast with reported adjuvant effects of Quil A on these types of antigens in mice. A conjugate prepared from the dephosphorylated L3,7,9 oligosaccharides evoked a significantly lower IgG response than a similar PEA-containing conjugate, and enzyme-linked immunosorbent assay inhibition studies indicated a different epitope specificity. Furthermore, antisera elicited with the complete bacteria contained antibodies directed against PEA-containing epitopes, which stresses the importance of the presence of unmodified PEA groups in meningococcal lipopolysaccharidederived oligosaccharide-protein conjugates. The procedure developed offers an elegant solution for the specffic coupling of meningococcal PEA-containing oligosaccharides to proteins and may therefore be a very useful tool in the development of a vaccine against group B meningococci.
Neisseria meningitidis may cause different clinical syndromes ranging from fulminant meningococcal septicemia with septic shock, multiple organ failure, and death to benign meningococcemia, but the most common presentation is meningitis. In the third world countries, an estimated 330,000 persons per year suffer from infections with N. meningitidis resulting in 35 ,000 deaths (28) . The precise underlying pathophysiological mechanisms leading to the different syndromes are not well known, but a recent study by Brandtzaeg et al. (3) suggested a direct correlation between the severity of systemic meningococcal disease (with regard to the development of septic shock, multiple organ failure, and death) and circulating levels of endotoxin (lipopolysaccharide [LPS] ).
The major problem in the development of a vaccine against this organism is presented by the group B meningococci. The group B capsular polysaccharide, which consists of a(2--8)-linked sialic acid residues, cannot be used for vaccination purposes because it is poorly immunogenic in humans (36) . It is possible to improve the immunogenicity of group B capsular polysaccharide by chemical modification and coupling to proteins, but this may not be desirable (14, 19) . Antibodies directed against altered group B capsular polysaccharide might cross-react with self-antigens because * Corresponding author. ot(2->8)-linked sialic acid residues are present on human gangliosides and on a number of fetal glycoproteins (12, 14) . Furthermore, it raises the difficult issue of how to evaluate a vaccine on its potential to induce autoantibodies and possibly autoimmune diseases. Therefore, outer membrane proteins and vaccines based on LPS are currently being studied as potential vaccine candidates (15, 27) .
The 12 different types of meningococcal LPS (immunotypes) differ with respect to monosaccharide composition, amount and location of phosphoethanolamine (PEA) groups, and acetylation of the individual monosaccharides (8, 16, 23 ) (see Fig. 1 for a basic structure). Jennings et al. (18) removed PEA from the meningococcal oligosaccharides (OS) by treatment with hydrogen fluoride. The dephosphorylated oligosaccharides (OS*) were then coupled to tetanus toxoid (TT) by reductive amination. The immunotype L3,7,9 OSprotein conjugate obtained, however, was only slightly immunogenic in rabbits, which can probably be attributed to the removal of the PEA groups. Nowadays, several methods are available for the coupling of LPS-derived polysaccharides or OS to proteins (6, 18, 30) . Unfortunately, no coupling procedure is suitable for the preparation of meningococcal OS-protein conjugates in which the PEA groups are preserved (6, 18, 30) . The existing methods are based on the introduction of a free amino group in the sugar moiety at the reducing end of the OS, often by sacrificing the ring structure of this residue. The free amino group is subsequently utilized L2 and L3,7,9. One PEA group is probably present in both immunotypes, but its precise location is not known. Furthermore, it is not known whether the a(1-*2) GlcNAc moiety of both immunotypes is acetylated or not.
for coupling to either an amino or a carboxylic acid function in the protein carrier. The presence of the PEA group in the meningococcal OS, which contains a free amino group, will lead to coupling of OS to OS or coupling of OS to proteins by the PEA group, resulting in the destruction of the immunotype-specific determinants.
In this report, we describe a well-defined coupling procedure for the preparation of PEA-containing LPS-derived OS-protein conjugates (see Fig. 2 for reaction scheme). A thiol group was introduced in the meningococcal OS by a two-step procedure. First, cystamine was coupled to the carboxylic acid residue of the terminal 2-keto-3-deoxyoctulosonic acid (KDO) moiety using 1-ethyl-3-dimethylaminopropylcarbodiimide (EDC) and N-hydroxysulfosuccinimide (Sulfo-NHS) (11, 29, 33) . Second, the thiol function was liberated by reduction with dithiothreitol (4). The amino groups of the protein were modified by reaction with N-succinimidyl bromoacetate, and the thiol-functionalized OS were coupled to the bromoacetylated proteins to give conjugates containing stable thioether linkages (1) . Another advantage of using this method is that to couple the OS to proteins, only the carboxylic acid group of the KDO molecule is slightly modified.
Immunotype L2 and L3,7,9 OS-TT conjugates were prepared, and the immune response to these conjugates was studied in rabbits both with and without the use of the adjuvant Quil A (13, 33) . To assess the role of the PEA group in the immunogenicity of immunotype L3,7,9 antigens, a (partial) dephosphorylated OS-protein conjugate was prepared and the immune response was compared with that of the PEA-containing conjugates. The specificity of the antibodies induced was analyzed by inhibition enzyme-linked (2) , followed by reduction with dithiothreitol (3) . Coupling of (1) to (1) by the already present free amino group is prevented by using excess amounts of cystamine. (B) Bromoacetyl groups are introduced in the proteins by using N-succinimidyl bromoacetate. (C) Thiol-functionalized oligosaccharides (3) are coupled to bromoacetylated proteins (5), giving conjugates with stable thioether linkages (6) . (17) . Excess HF was removed in a desiccator over NaOH pellets, and the mixture was subsequently neutralized with a 25% NH3 solution. The mixture was purified over a Bio-Gel P-2 column equilibrated in bidistilled water. The main OS and OS* fractions, containing molecules with the highest molecular weight, were used for the preparation of the conjugates. LPS, OS, and OS* were analyzed for monosaccharide composition (20) , amino group content (21) , and phosphate content (5).
MATERIALS AND METHODS
Modffication of OS. Cystamine HCI (Sigma Chemical Co.) was coupled to OS by carbodiimide-mediated condensation using EDC (Sigma Chemical Co.) and Sulfo-NHS (Pierce Chemical Co., Rockford, Ill.) (11, 29, 33) . OS (60 mg -37. 5 ,umol) was dissolved in bidistilled water (10 mg/ml) and cooled to 4°C. Cystamine HCl and Sulfo-NHS were added as solids to concentrations of 1.0 M and 8 mM, respectively. The pH was adjusted to 4.8 with 0.2 M HCl, and EDC was added as a solid to a concentration of 0.1 M. The reaction mixture was stirred at pH 4.8 for 3 h. The solution was adjusted to pH 7.0 and applied to a Sephadex G-25 column (diameter = 2.8 cm, length = 49 cm) equilibrated in bidistilled water. The eluent was assayed for sugar (9) and amino group (21) content. The first peak containing amino groupand sugar-positive fractions (OS coupled to OS by the spacer molecule) and the second peak containing sugar-and strong amino group-positive fractions (OS containing the spacer molecule) were pooled and lyophilized. The eluent was monitored for total sugar and thiol group content (9, 10). Sugar-and thiol-positive fractions were only detected in the first peak, so no detectable amounts of OS coupled to OS were present. These fractions were pooled and stored at 4°C under a helium atmosphere. OS-SH (=50 mg) was added to bromoacetylated TT (=10 mg) (TT-AcBr) and stirred for 27 h at room temperature under a helium atmosphere. To block the remaining bromoacetyl groups on the protein, 43.3 mg of cystamine HCl (100 molar excess to the number of bromoacetyl groups present in TT) was added and the reaction mixture was stirred overnight at room temperature. The OS-TT conjugate was purified over a Sepharose CL-6B column (diameter = 1.5 cm, length = 60 cm) equilibrated in 0.2 M NaCl (containing 0.01% NaN3). The eluent was monitored for protein (2) and sugar content. Appropriate fractions were pooled and concentrated over a micron B-15 filter (cutoff value, 15,000; Amicon BV, Oosterhout, The Netherlands). The conjugates were analyzed for total sugar content (9), protein content (2), phosphate content (5), and monosaccharide composition (20) . L3,7,9 OS*-TT and L2 OS-TT conjugates were prepared by similar procedures.
Antibody determination in serum. To determine antibodies in serum, blood was withdrawn from ELCO rabbits and sera were prepared and stored at -20°C. Immunotype L3,7,9-and L2-specific antibodies were detected by an ELISA. Polyvinyl chloride 96-well microdilution plates (Titertek 77-176-05 activated; Flow Laboratories, Zwanenburg, The Netherlands) were coated with 10,ug of purified L3,7,9 or L2 LPS per ml in 0.1 M carbonate buffer (pH 9.6) overnight at 37°C. The plates were washed three times with tap water containing 0.02% Tween 80. Next, the plates were incubated for 2 h at 37°C with a test serum dilution in phosphatebuffered saline containing 0.02% Tween 80 and 1% bovine serum albumin (fatty acid free; Sigma Chemical Co. (22, 34) . The effective dose was calculated as follows: log1o (dilution of test serum giving an A450 of 0.500) -log1o (dilution of a reference serum giving an A450 of 0.500). Antibody levels were determined in each antiserum, and the results were expressed, when appropriate, as mean standard deviation. As reference sera, immunotype-specific rabbit antisera were used which were obtained from rabbits after multiple injections with a meningococcal L3,7,9 strain or L2 strain. The IgG antibody titer of both the L2 and L3,7,9 reference antisera was 10,000 (dilution needed to reach an absorbance of 0.5).
Inhibition 
RESULTS
Chemical analysis of LPS, OS, and OS*. Isolated LPS, OS, and OS* of immunotypes L2 and L3,7,9 were analyzed for monosaccharide composition, phosphate content, and amino group content (Table 1 ). The monosaccharide composition of L3,7,9 LPS was similar to the monosaccharide composition of L2 LPS, but L3,7,9 LPS contained much higher amounts of phosphate. Sugar analysis of L3,7,9 and L2 OS showed the presence of an extra glucose in the L2 OS. OS of both immunotypes possessed one PEA group, but in L3,7,9 OS higher amounts of amino groups were detected. Dephosphorylation of immunotype L2 and L3,7,9 OS by treatment with HF resulted in a decrease in phosphate and amino groups, but no differences in monosaccharide composition were observed. (Table 2 ). Higher concentrations of OS-SH and TT-AcBr resulted in a higher carbohydrate/protein ratio, while the molar ratio between the two compounds, in the range studied, seemed to have a minor influence.
Chemical analysis of the conjugates. Phosphate groups were detected in all the conjugates prepared with PEAcontaining OS but not in the conjugate synthesized with the partially dephosphorylated (80%) OS (Table 3) . To confirm the presence of the OS in the conjugates, we did a monosaccharide analysis. In all the conjugates, OS were detected, but the monosaccharide composition of the L3,7,9 conju- Fig. 3A and B) . Although the IgG antibody pattern evoked with the (OS*)15-TT conjugate was similar to the IgG immune response induced by the PEA group-containing conjugates (Fig. 3C) , the amount of IgG antibodies induced was significantly lower compared with the IgG response elicited with the (OS)15-TT conjugate (a factor of 9 lower at day 28 and a factor of 4 lower at day 35) (P < 0.05). In striking contrast with the L3,7,9 conjugates, L3,7,9 LPS was not able to induce an IgG antibody response above background level (Fig. 3D) .
To study the influence of Quil A on the immune response, we immunized groups of rabbits with the same antigens in combination with 100 ,ug of Quil A. Only minor increases in IgG antibody levels were observed compared with those in rabbits immunized with the antigens alone.
Immunogenicity of the L2 conjugate. Rabbits were immunized s.c. at days 0 and 21 with either 60 ,ug of L2 (OS)21-TT or 30 jig of L2 LPS both with and without the addition of Quil A. IgM, IgG, and IgA antibody levels were measured by an L2-specific ELISA. Rabbits immunized with the L2 conjugate displayed an IgG antibody pattern similar to that of animals injected with L3,7,9 conjugates (Fig. 4A) . In contrast with the L3,7,9 immunotype, high IgG preimmune titers against the L2 immunotype were already present in some rabbits (Fig. 4) . L2 LPS in combination with Quil A induced a substantial IgG titer, while after injection with L2 LPS alone, no increase in IgG antibody level was observed.
In this rabbit, however, high levels of anti-L2 IgG antibodies were present at day 0.
Duration of the L3,7,9 immune response in rabbits. To investigate the duration of the L3,7,9 immune response, we immunized rabbits s.c. with the L3,7,9 (OS)15-TT conjugate both with and without the addition of Quil A at days 0 and 21. As a negative control, a rabbit was injected with Quil A alone. Antibody titers were measured at days 0, 28, and 35 and after 9 months. Even after 9 months, substantial IgG antibody titers were still present, while the immunization with Quil A alone did not result in the induction of L3,7,9-specific IgG antibodies (Fig. 5A) .
To study the effect of a second booster injection, we injected rabbits s.c. at days 0, 21, and 63 with the L3,7,9 (OS)20-TT conjugate both with and without the addition of Quil A. Titers were measured at days 0, 14, 28, 35, 56, and 70. The antibody titers present at day 56 were comparable to the titers at day 35, while after the second booster injection at day 63, the IgG antibody levels increased (Fig. 5B) .
Specificity of induced immune responses. To check the specificity of the immune responses, we performed extensive inhibition studies in which LPS, OS, and OS* were used as inhibitors. Antisera evoked with the OS-protein conjugates could always be inhibited with the homologous LPS, OS, and OS*, although different amounts of the inhibitors were needed for 50% inhibition ( Table 4 ). The 50% inhibition patterns for the L3,7,9 PEA group-containing conjugates differed considerably from the patterns obtained for the dephosphorylated L3,7,9 conjugate. Antisera obtained from rabbits immunized with whole L2 or L3,7,9 cells displayed a similar 50% inhibition pattern: LPS < OS < OS*. Preimmune sera with a high titer against the L2 immunotype could only be inhibited with the complete L2 LPS.
DISCUSSION
To be used as vaccines, LPS-derived polysaccharides or OS have to be coupled to carrier proteins (7) . However, of the various coupling methods available, no procedure is suitable for the preparation of PEA-containing LPS-derived OS-protein conjugates (6, 18, 30) . This report describes a well-defined procedure for the coupling to proteins of polysaccharides or OS in which both a carboxylic acid group and a PEA group are present. LPS, OS, and OS* preparations were analyzed for monosaccharide composition, phosphate content, and amino group content (Table 1 ). The monosaccharide compositions of L2 LPS and L3,7,9 LPS were almost similar, which is not in agreement with the published OS structures of the two immunotypes ( Fig. 1) (16) . In contrast, the sugar analysis of the L2 and L3,7,9 OS showed the presence of the extra glucose in the L2 OS, while the amounts of other monosaccharides were comparable to the theoretical values (molecular ratio between Gal, Glc, GlcNac, KDO is 2:1:2:1 and 2:2:2:1 for immunotypes L3,7,9 and L2, respectively). Furthermore, both immunotypes contained one PEA group, and dephosphorylation of the L2 and L3,7,9 OS resulted only in a decrease in the amount of phosphate and amino groups, indicating the presence of intact OS* and no degradation products (Table 1) . From our chemical analysis, however, it was not possible to conclude whether a heterogeneous mixture of OS was obtained or whether only one type of OS was obtained. In general, a heterogeneous mixture of OS is isolated after hydrolysis of LPS by 1% acetic acid and purification over a single gel permeation column (8, 23) . These OS differ in monosaccharide composition, acetylation of monosaccharides, and PEA group content (8, 23) . Therefore, we assumed that heterogeneous mixtures of OS and The use of the developed procedure enabled the specific coupling of PEA-containing OS and OS* to TT ( Table 2 ). The presence of the meningococcal OS and OS* in the conjugates was confirmed by sugar analysis (Table 3) . Phosphate groups were only detected in the conjugates prepared with the PEA-containing OS, indicating the presence of PEA groups. The monosaccharide composition of the L3,7,9 conjugates, however, differed considerably from the monosaccharide composition of the L3,7,9 OS and L3,7,9 OS*. These differences can probably be attributed to contamination during the concentration step on the micron filter (higher Glc content), to the modification and coupling of KDO to TT (lower amounts or no detection of KDO [L2 conjugate]), or to the possibility that certain monosaccharides are less well detected in the presence of proteins (GlcNAc). Another explanation is that not all the OS molecules present in the OS isolation contain KDO, while only KDO-containing OS are coupled to TT.
Various conjugates were prepared and the influence of two factors on the carbohydrate/protein ratio of the conjugates was studied ( Table 2 ). The carbohydrate/protein ratio of the conjugates was mainly determined by the concentration of OS-SH and TT-AcBr present in the reaction mixture, while the molar ratio between those two compounds seemed to have a minor influence. In general, to prepare immunogenic conjugates, a concentration of 1 mg of TT-AcBr per ml and 3 to 6 mg of OS-SH per ml is needed (Table 2 ; Fig. 3, 4 , and 5). Both immunotype L2 and immunotype L3,7,9 PEAcontaining OS-TT conjugates were highly immunogenic in rabbits (Fig. 3, 4 , and 5). Immunization with these conjugates alone elicited a strong IgG response after the first booster injection which could be slightly increased with a second booster injection (Fig. 3A and B, 4A, and SA) . The IgG responses induced were much higher than the IgG responses evoked with native L3,7,9 LPS and L2 LPS (Fig.  3D and 4B) . Moreover, these conjugates displayed an ability to induce long-lasting IgG antibody titers. Even after 9 months, substantial IgG antibody levels were detected in [IAL F 28 35 INFECT. IMMUN. (Fig. 3A and C) . As can be expected from the similarity in OS structure between the two immunotypes ( Fig. 1 ), antisera evoked with immunotype L2 or L3,7,9 antigens always displayed a cross-reactivity with the heterologous immunotype (data not shown).
The adjuvant Quil A is a semipurified saponin that is used for the preparation of immunostimulating complexes (24) . Quil A stimulates the immune response against both thymusindependent and thymus-dependent antigens (13, 31, 33 (25, 26) . Most of these studies, however, are performed in mice, and limited data are available about the adjuvant effects of Quil A in rabbits (31) . Our results indicate that the use of Quil A is only marginally effective for the increase of the humoral immune response against OS-protein conjugates in rabbits. It stimulated the IgG immune response to all the conjugates only to a minor extent, but surprisingly, it seemed to influence the epitope specificity of the antibodies induced by the PEAcontaining conjugates (34a). Therefore, the adjuvant activity of Quil A depends not only on the type of antigen used (13, Sera were obtained at day 35. The preimmune serum contained a high titer against the L2 immunotype. The reference sera were evoked by multiple immunizations with an L3,7,9 or L2 strain. 31, 33) but also on the experimental animal in which the preparations are tested.
The specificities of the antibodies induced were analyzed by ELISA inhibition experiments using the homologous LPS, OS, and OS* as inhibitors (Table 4) . Antibodies evoked with the conjugates were always directed against epitopes located on the OS part of the LPS molecule because every antiserum could be inhibited with both the complete homologous LPS, OS, and partially dephosphorylated OS. Different 50% inhibition patterns between the various antisera, however, were observed, indicating a difference in epitope specificity. Antisera evoked with a PEA-containing conjugate showing a 50% inhibition pattern of LPS < OS << OS* probably contain antibodies directed against PEA group-containing epitopes. In contrast, antibodies in antisera with a 50% inhibition pattern of L3,7,9 LPS < L3,7,9 OS = L3,7,9 OS* recognize common epitopes present on the L3,7,9 OS and the L3,7,9 OS*. The epitope specificity of the antibodies induced by the PEA group-containing conjugates depends on the immunotype of the conjugate, the rabbit used, and possibly the use of the adjuvant Quil A (34a).
The 50% inhibition patterns of antisera evoked with a dephosphorylated L3,7,9 conjugate differed completely from 50% inhibition patterns evoked with the PEA-containing conjugates. These antibodies possessed a high avidity for the L3,7,9 OS* and were directed against epitopes present on the L3,7,9 OS*. Antisera induced by multiple injections with whole L2 or L3,7,9 organisms, in which LPS is present in its native conformation, displayed a similar 50% inhibition pattern: LPS < OS << OS*. These patterns indicate that in both irpmunotypes, the PEA groups are part of the immunodominant determinants, and they stress the importance of the presence of those groups in the meningococcal LPSderived OS-protein conjugates.
Anti-L2 and -L3,7,9 IgM antibodies and sometimes anti-L2-specific IgG antibodies were detected in the preimmune sera. These antibodies are part of the natural anti-lipid A antibody levels present in these rabbits because only the -or lipid A and not the OS or OS* were able to -tisera (Table 4 ; data not shown). neningococcal OS-TT conjugates, Jennings et ;o remove certain epitopes present on the meningococcal OS molecules. The PEA groups were taken off and the ring structure of the KDO residue was sacrificed to couple the OS molecules to TT. Of the different immunotype conjugates prepared, the L3,7,9 conjugate in combination with Freund complete adjuvant was only slightly immunogenic in rabbits, inducing low antibody levels against the L3,7,9 LPS and the L2 LPS (18) .
Our coupling procedure has the advantage over the method used by Jennings et al. (18) in that it succeeds in the coupling of PEA-containing OS to TT with only a minor modification of the KDO residue (Tables 2 and 3 ). The conjugates prepared induced high IgG antibody levels without the use of an adjuvant (Fig. 3, 4, and 5 ). These conjugates were also able to induce long-lasting IgG antibody titers. Dephosphorylation of OS resulted in conjugates with a lower immunogenicity compared with similar PEA-containing conjugates, while the antibodies induced possessed a different epitope specificity ( Fig. 3A and C; Table 4 ). Furthermore, inhibition studies with antisera evoked with whole organisms indicated that PEA groups are part of the immunodominant determinants of the L3,7,9 and L2 immunotypes.
Outer membrane protein-and LPS-based vaccines are currently being studied as potential candidates for a vaccine against group B meningococci. In our view, the best possible candidate is an LPS-derived OS-outer membrane protein conjugate because it combines the potential advantages of both components. Especially, incorporation of components that neutralize the effects mediated by LPS might be very beneficial for the efficacy of a group B meningococcal vaccine because results of Brandtzaeg et al. (3) suggested a direct correlation between the fatal outcome of systemic meningococcal disease and circulating levels of LPS. The method developed offers an elegant solution for the selective coupling of carboxylic acid-and PEA-containing polysaccharides or OS to proteins and may therefore be a very useful tool in the development of a vaccine against group B meningococci.
